COGT Cogent Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 10, 2026
$31,02
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$13,7852 haftanın en düşüğü
$43,7352 haftanın en yükseği
Piyasa Değeri (MRQ)
$5.32B
P/E
-14.4
Hisse Başına Kâr
$-2.16
rozetleriniz
52 Haftlık Aralık
$14–$44
Analist Derecelendirmesi
STRONG BUY
Fiyat Hedefi
$56
P/E
-14.4
ROE
-83.1%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
COGT Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$31.02
Piyasa Değeri (MRQ)
$5.32B
P/E
-14.4
Hisse Başına Kâr
$-2.16
ROE
-83.1%
52 Haftlık Aralık
$14–$44
COGT Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 09 Kasım 2020 | 1-for-4 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir·2017-12-31 → 2020-12-31
Hisse Başına Kâr$-2.162021-12-31 → 2025-12-31
Serbest Nakit Akışı$-266M2018-12-31 → 2025-12-31
Net kar marjı·2018-12-31 → 2020-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | COGT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -14.45Y ort. ≈-7.0 | ≈-7.0 | · | · | |
| P/S (F/S) | 215.65Y ort. ≈71.4 | ≈71.4 | 60.4 | Aşırı değerli | |
| F/D (MRQ) | 10.05Y ort. ≈3.8 | ≈3.8 | 9.3 | Daha pahalı | |
| Fiyat / Serbest Nakit Akışı (TTM) | -17.25Y ort. ≈-8.3 | ≈-8.3 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -17.35Y ort. ≈-8.5 | ≈-8.5 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 7.85Y ort. ≈3.8 | ≈3.8 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | COGT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -52.0%5Y ort. ≈-55.4% | ≈-55.4% | -22.3% | Zayıf | |
| ROE | -83.1%5Y ort. ≈-65.6% | ≈-65.6% | -35.2% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | COGT | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 13.65Y ort. ≈9.9 | ≈9.9 | 9.6 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 4.95Y ort. ≈5.2 | ≈5.2 | 5.0 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
2.0%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 11, 2026 | $-0.52 | $-0.58 | 10.5% |
| 31 Mart 2026 | May 12, 2026 | $-0.60 | $-0.55 | -8.8% |
| 31 Aralık 2025 | $-0.64 | $-0.53 | -20.9% | |
| 30 Eylül 2025 | $-0.50 | $-0.54 | 7.1% | |
| 30 Haziran 2025 | $-0.53 | $-0.60 | 11.4% | |
| 31 Mart 2025 | $-0.52 | $-0.60 | 12.9% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $8M | $22M | $10M | $8M | |
| R&D Expense | $270M | $233M | $174M | $122M | $56M | $26M | $44M | $38M | $30M | |
| SG&A Expense | $64M | $43M | $34M | $26M | $20M | $17M | $11M | $7M | $5M | |
| Operating Expenses | $333M | $276M | $208M | $148M | $76M | $90M | $55M | $46M | $35M | |
| Operating Income | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | $-26M | |
| Interest Income | $15M | $18M | $13M | $4M | $467.0K | $144.0K | $267.0K | $1M | $386.0K | |
| Other Non-op | $-20.0K | $2M | $943.0K | $2M | $3M | $7M | $345.0K | $320.0K | $274.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | $-25M | |
| EPS (Basic) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| EPS (Diluted) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | · | · | · | · | |
| Shares (Basic) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| Shares (Diluted) | 128,899,408 | 103,856,611 | 79,657,942 | 58,739,713 | 38,730,813 | · | · | · | · | |
| EBITDA | $-333M | $-276M | $-208M | $-148M | $-76M | $-82M | $-32M | $-36M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $312M | $98M | $53M | $140M | $220M | $242M | $37M | $56M | $28M | |
| Short-term Investments | · | · | · | · | · | · | · | $23M | $13M | |
| Receivables | · | · | · | · | · | · | $2M | $2M | $830.0K | |
| Prepaid Expense | $10M | $9M | $5M | $4M | $3M | $3M | $1M | $740.0K | $513.0K | |
| Current Assets | $910M | $296M | $271M | $265M | $223M | $245M | $41M | $81M | $42M | |
| PP&E (Net) | $5M | $6M | $8M | $8M | $2M | $134.0K | $2M | $3M | $4M | |
| PP&E (Gross) | $14M | $13M | $12M | $9M | $2M | $546.0K | $6M | $7M | $6M | |
| Accum. Depreciation | $9M | $6M | $4M | $1M | $559.0K | $412.0K | $5M | $3M | $2M | |
| Other Non-current Assets | $3M | $5M | $5M | $5M | $4M | · | $427.0K | $419.0K | · | |
| Total Assets | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Accounts Payable | $10M | $12M | $11M | $6M | $3M | $732.0K | $3M | $2M | $1M | |
| Current Liabilities | $64M | $56M | $38M | $27M | $17M | $13M | $13M | $25M | $11M | |
| Capital Leases | $14M | $16M | $17M | $18M | $831.0K | $3M | $4M | · | · | |
| Other Non-current Liabilities | $33.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $301M | $72M | $56M | $45M | $18M | $16M | $18M | $26M | $21M | |
| Long-term Debt | $223M | · | · | · | · | · | · | · | · | |
| Common Stock | $161.0K | $110.0K | $86.0K | $70.0K | $44.0K | $32.0K | $8.0K | $30.0K | $10.0K | |
| Retained Earnings | $-1.19B | $-859M | $-604M | $-411M | $-271M | $-199M | $-124M | $-92M | $-51M | |
| AOCI | $355.0K | $447.0K | $246.0K | $-104.0K | · | · | · | $-12.0K | $-16.0K | |
| Stockholders' Equity | $636M | $256M | $258M | $256M | $214M | $235M | $32M | $60M | $-49M | |
| Liabilities + Equity | $938M | $328M | $313M | $301M | $232M | $251M | $49M | $86M | $49M | |
| Shares Outstanding | 160,980,024 | 110,461,729 | 86,124,249 | 69,893,434 | 43,805,922 | 32,347,905 | 7,665,763 | 30,057,970 | 10,201,690 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $2M | $800.0K | $147.0K | $720.0K | $1M | $1M | $1M | |
| Stock-based Comp | $46M | $40M | $31M | $18M | $12M | $6M | $3M | $3M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Restructuring | · | · | · | · | · | $4M | · | · | · | |
| Operating Cash Flow | $-264M | $-208M | $-154M | $-119M | $-59M | $-36M | $-42M | $-32M | $-26M | |
| CapEx | $2M | $573.0K | $3M | $7M | $2M | · | $33.0K | $549.0K | $912.0K | |
| Investing Cash Flow | $-400M | $38M | $-98M | $-125M | $-2M | $8M | $23M | $-11M | $14M | |
| Debt Issued | $49M | $0 | $0 | · | · | · | · | · | · | |
| Net Debt Issued | $49M | · | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $162M | $0 | $0 | $25M | $108.0K | $609.0K | $60.0K | |
| Net Stock Activity | · | $0 | $162M | · | · | $25M | $108.0K | $609.0K | · | |
| Financing Cash Flow | $878M | $214M | $164M | $164M | $38M | $232M | $108.0K | $70M | $-729.0K | |
| Net Change in Cash | $214M | $45M | $-88M | $-80M | $-23M | $205M | $-18M | $27M | $-13M | |
| Taxes Paid | $0 | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-266M | $-208M | $-156M | $-126M | $-60M | · | $-42M | $-33M | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| Net Margin | · | · | · | · | · | -950.4% | -141.5% | -354.8% | · | |
| EBITDA Margin | · | · | · | · | · | -1044.3% | -143.0% | -369.9% | · | |
| ROA | -52.0% | -79.8% | -62.6% | -52.6% | -29.9% | -49.8% | -47.0% | -51.1% | · | |
| ROE | -83.1% | -89.6% | -68.6% | -51.4% | -35.1% | -70.4% | -105.4% | -54.1% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 | 18.7 | 3.1 | 3.2 | · | |
| Quick Ratio | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 | 18.5 | 3.0 | 3.2 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.1 | 0.3 | 0.1 | · | |
| Receivables Turnover | · | · | · | · | · | · | 12.3 | 7.8 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.95 | $2.32 | $2.99 | $3.66 | $4.89 | $7.25 | $1.04 | $2.00 | · | |
| Cash Flow / Share | $-2.05 | $-2.00 | $-1.93 | $-2.02 | · | · | · | · | · | |
| Cash / Share | $1.94 | $0.89 | $0.62 | $2.00 | $5.01 | $7.49 | $1.22 | $1.85 | · | |
| EPS (TTM) | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 | $-1.05 | $-1.05 | $-1.60 | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $23M | $23M | $23M | $23M | $23M | $8M | $22M | $10M | · | |
| Net Income TTM | $-329M | $-256M | $-192M | $-140M | $-72M | $-75M | $-32M | $-35M | · | |
| Market Cap | $5.72B | $862M | $506M | $808M | $376M | $363M | $88M | $529M | · | |
| P/E | -16.4 | -4.0 | -3.0 | -6.7 | -4.6 | -10.7 | -2.7 | -11.0 | · | |
| P/S | 246.9 | 37.2 | 21.9 | 34.9 | 16.2 | 46.2 | 3.9 | 54.3 | · | |
| P/B | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | 2.8 | 8.8 | · | |
| P / Tangible Book | 9.0 | 3.4 | 2.0 | 3.2 | 1.8 | 1.5 | · | · | · | |
| P / Cash Flow | -21.6 | -4.1 | -3.3 | -6.8 | -6.4 | -10.1 | -2.1 | -16.3 | · | |
| P / FCF | -21.5 | -4.1 | -3.2 | -6.4 | -6.2 | · | -2.1 | -16.0 | · | |
| Earnings Yield | -6.1% | -24.9% | -33.0% | -15.0% | -21.8% | -9.3% | -36.5% | -9.1% | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $71M | $75M | $76M | $69M | $62M | $63M | $62M | $64M | $54M | $53M | $50M | $39M | $36M | $30M | $29M | $25M | |
| SG&A Expense | $32M | $28M | $24M | $14M | $13M | $12M | $12M | $12M | $10M | $10M | $9M | $8M | $7M | $7M | $6M | $6M | |
| Operating Expenses | $103M | $104M | $99M | $83M | $76M | $75M | $74M | $75M | $64M | $62M | $60M | $47M | $43M | $37M | $36M | $31M | |
| Operating Income | $-103M | $-104M | $-99M | $-83M | $-76M | $-75M | $-74M | $-75M | $-64M | $-62M | $-60M | $-47M | $-43M | $-37M | $-36M | $-31M | |
| Interest Income | $7M | $8M | $5M | $4M | $2M | $3M | $4M | $5M | $5M | $4M | $4M | $3M | $2M | $2M | $272.0K | $107.0K | |
| Other Non-op | $-11.0K | $-140.0K | $-6.0K | $-3.0K | $-6.0K | $-5.0K | $2M | $1.0K | $44.0K | $-1.0K | $0 | $268.0K | $682.0K | $2M | $928.0K | $784.0K | |
| Net Income | $-96M | $-97M | $-102M | $-81M | $-74M | $-72M | $-68M | $-71M | $-59M | $-58M | $-55M | $-44M | $-39M | $-35M | $-35M | $-31M | |
| EPS (Basic) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.64 | $-0.59 | $-0.55 | $-0.50 | $-0.71 | $-0.68 | |
| EPS (Diluted) | $-0.52 | $-0.53 | $-0.61 | $-0.50 | $-0.53 | $-0.52 | $-0.50 | $-0.52 | $-0.43 | $-0.49 | $-0.64 | $-0.59 | $-0.55 | $-0.50 | $-0.71 | $-0.68 | |
| Shares (Basic) | 171,005,468 | 162,194,778 | · | 137,550,159 | 114,466,080 | 113,307,940 | · | 110,165,580 | 99,240,030 | 94,804,659 | 86,165,951 | 74,753,269 | 70,734,950 | 69,576,359 | 49,388,936 | 45,105,923 | |
| Shares (Diluted) | 171,005,468 | 162,194,778 | · | 137,550,159 | 114,466,080 | 113,307,940 | · | 110,165,580 | 99,240,030 | 94,804,659 | 86,165,951 | 74,753,269 | 70,734,950 | 69,576,359 | 49,388,936 | 45,105,923 | |
| EBITDA | $-103M | $-104M | · | $-83M | $-76M | $-75M | · | $-75M | $-64M | $-62M | $-60M | $-47M | $-43M | $-37M | $-36M | $-31M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $181M | $241M | $312M | $125M | $128M | $126M | $98M | $97M | $88M | $216M | $87M | $214M | $161M | $141M | $326M | $191M | |
| Prepaid Expense | $13M | $11M | $10M | $6M | $7M | $7M | $9M | $6M | $7M | $6M | $7M | $5M | $5M | $6M | $4M | $4M | |
| Current Assets | $805M | $878M | $910M | $397M | $245M | $253M | $296M | $342M | $370M | $442M | $286M | $335M | $226M | $296M | $331M | $195M | |
| PP&E (Net) | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $8M | $9M | $9M | $9M | $7M | $4M | $2M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $13M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $6M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $2M | $3M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Total Assets | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | $355M | $392M | $263M | $332M | $366M | $207M | |
| Accounts Payable | $7M | $14M | $10M | $16M | $17M | $14M | $12M | $15M | $9M | $16M | $10M | $7M | $4M | $4M | $3M | $4M | |
| Current Liabilities | $59M | $58M | $64M | $62M | $58M | $49M | $56M | $53M | $40M | $37M | $35M | $26M | $21M | $24M | $28M | $18M | |
| Capital Leases | $19M | $14M | $14M | $15M | $15M | $15M | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $18M | $19M | $1M | |
| Other Non-current Liabilities | $90.0K | $62.0K | $33.0K | $2M | $2M | $5.0K | $0 | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $302M | $295M | $301M | $123M | $120M | $65M | $72M | $69M | $57M | $54M | $53M | $44M | $40M | $42M | $47M | $19M | |
| Long-term Debt | $223M | $223M | $223M | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | · | · | $44M | $44M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $171.0K | $171.0K | $161.0K | $141.0K | $114.0K | $114.0K | $110.0K | $110.0K | $109.0K | $96.0K | $86.0K | $85.0K | $71.0K | $70.0K | $66.0K | $46.0K | |
| Retained Earnings | $-1.38B | $-1.29B | $-1.19B | $-1.09B | $-1.00B | $-931M | $-859M | $-792M | $-721M | $-662M | $-549M | $-494M | $-450M | $-372M | $-337M | $-302M | |
| AOCI | $-770.0K | $-415.0K | $355.0K | $208.0K | $13.0K | $164.0K | $447.0K | $896.0K | $-192.0K | $-39.0K | $-172.0K | $-97.0K | $16.0K | $-163.0K | · | · | |
| Stockholders' Equity | $532M | $608M | $636M | $302M | $155M | $219M | $256M | $315M | $373M | $422M | $303M | $348M | $224M | $290M | $319M | $188M | |
| Liabilities + Equity | $835M | $903M | $938M | $426M | $275M | $284M | $328M | $384M | $430M | $476M | $355M | $392M | $263M | $332M | $366M | $207M | |
| Shares Outstanding | 171,598,409 | 170,773,803 | 160,980,024 | 139,827,662 | 113,928,492 | 113,856,454 | 110,461,729 | 110,458,249 | 109,343,224 | 95,613,396 | 86,124,249 | 85,334,165 | 70,946,790 | 69,857,972 | 65,707,714 | 45,819,266 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $741.0K | $626.0K | $664.0K | $641.0K | $655.0K | $640.0K | $675.0K | $620.0K | $606.0K | $599.0K | $581.0K | $562.0K | $529.0K | $256.0K | $97.0K | $69.0K | |
| Stock-based Comp | $17M | $17M | $16M | $11M | $10M | $10M | $10M | $10M | $10M | $9M | $9M | $7M | $6M | $5M | $5M | $4M | |
| Operating Cash Flow | $-77M | $-87M | $-79M | $-64M | $-55M | $-67M | $-61M | $-52M | $-43M | $-53M | $-38M | $-32M | $-40M | $-34M | $-26M | $-28M | |
| CapEx | $370.0K | $449.0K | $811.0K | $65.0K | $131.0K | $547.0K | $75.0K | $280.0K | $148.0K | $70.0K | $121.0K | $1M | $1M | $3M | $1M | $441.0K | |
| Investing Cash Flow | $14M | $-36M | $-323M | $-155M | $9M | $69M | $62M | $60M | $-85M | $1M | $-91M | $-78M | $60M | $-152M | $-1M | $-441.0K | |
| Debt Issued | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | $-170.0K | · | · | · | · | · | |
| Financing Cash Flow | $3M | $53M | $589M | $217M | $47M | $25M | $26.0K | $624.0K | $-256.0K | $214M | $1M | $162M | $445.0K | $990.0K | $162M | $138.0K | |
| Net Change in Cash | $-60M | $-71M | $187M | $-2M | $2M | $28M | $1M | $9M | $-128M | $163M | $-128M | $52M | $21M | $-185M | $135M | $-29M | |
| Free Cash Flow | · | $-87M | · | · | · | $-67M | · | · | · | $-53M | · | · | $-41M | · | · | $-29M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.4% | -16.4% | · | -20.0% | -20.9% | -18.9% | · | -19.1% | -14.3% | -15.8% | -16.1% | -11.6% | -16.4% | -12.8% | -11.8% | -13.8% | |
| ROE | -28.1% | -23.5% | · | -26.2% | -27.8% | -22.4% | · | -22.9% | -16.3% | -18.1% | -18.7% | -13.2% | -18.8% | -14.4% | -13.1% | -14.8% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.6 | 15.1 | · | 6.4 | 4.2 | 5.1 | · | 6.4 | 9.2 | 12.0 | 8.2 | 13.0 | 10.7 | 12.6 | 12.0 | 10.9 | |
| Quick Ratio | 3.1 | 4.2 | · | 2.0 | 2.2 | 2.6 | · | 1.8 | 2.2 | 5.9 | 2.5 | 8.3 | 7.6 | 6.0 | 11.8 | 10.7 | |
| Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.1 | 0.3 | · | · | · | · | · | · | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.10 | $3.56 | · | $2.16 | $1.36 | $1.92 | · | $2.85 | $3.41 | $4.42 | $3.52 | $4.08 | $3.15 | $4.15 | $4.86 | $4.10 | |
| Cash Flow / Share | · | $-0.54 | · | · | · | $-0.59 | · | · | · | $-0.55 | · | · | $-0.56 | · | · | · | |
| Cash / Share | $1.06 | $1.41 | · | $0.90 | $1.12 | $1.11 | · | $0.88 | $0.81 | $2.26 | $1.01 | $2.51 | $2.27 | $2.01 | $4.95 | $4.17 | |
| EPS (TTM) | $-2.16 | $-2.17 | · | $-2.05 | $-2.07 | $-1.97 | · | $-1.60 | $-1.72 | $-1.88 | $-1.62 | $-1.48 | $-1.60 | $-2.51 | $-2.49 | $-2.21 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $8M | · | $8M | $8M | $8M | · | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Net Income TTM | $-377M | $-354M | · | $-294M | $-284M | $-269M | · | $-242M | $-227M | $-212M | $-178M | $-157M | $-148M | $-126M | $-110M | $-91M | |
| Market Cap | $6.64B | $6.57B | · | $2.01B | $818M | $682M | · | $1.19B | $922M | $643M | $840M | $1.01B | $766M | $1.04B | $593M | $343M | |
| Enterprise Value | · | · | · | $1.93B | $734M | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -17.9 | -17.7 | · | -7.0 | -3.5 | -3.0 | · | -6.8 | -4.9 | -3.6 | -6.0 | -8.0 | -6.7 | -5.9 | -3.6 | -3.4 | |
| P/S | 843.7 | 835.1 | · | 255.1 | 103.9 | 86.6 | · | 151.6 | 117.1 | 81.6 | 106.7 | 128.4 | 97.3 | 132.4 | 75.3 | 43.6 | |
| P/B | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | 2.8 | 2.9 | 3.4 | 3.6 | 1.9 | 1.8 | |
| P / Tangible Book | 12.5 | 10.8 | · | 6.6 | 5.3 | 3.1 | · | 3.8 | 2.5 | 1.5 | 2.8 | 2.9 | 3.4 | 3.6 | 1.9 | 1.8 | |
| P / Cash Flow | · | -75.7 | · | · | · | -10.3 | · | · | · | -12.2 | · | · | -19.4 | · | · | -12.1 | |
| EV / Revenue | · | · | · | 244.8 | 93.3 | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -5.6% | -5.6% | · | -14.3% | -28.8% | -32.9% | · | -14.8% | -20.4% | -28.0% | -16.6% | -12.5% | -14.8% | -16.8% | -27.6% | -29.5% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-329M | $-256M | $-192M | $-140M | $-72M |
| Seyreltilmiş Hisse Başı Kâr | $-2.16 | $-1.94 | $-1.94 | $-1.73 | $-1.87 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 14.2 | 5.3 | 7.1 | 9.9 | 13.0 |
| Cari Oran | 4.9 | 1.8 | 1.4 | 5.2 | 12.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-266M | $-208M | $-156M | $-126M | $-60M |
Kurumsal Sahipler (13F) 340 dosya · $7.6B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
340
Tutulan Değer
$7.6B
Yeni pozisyonlar
65
Çıkan pozisyonlar
41
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 65 (-17 önceki Ç'ye göre) | 41 (+7 önceki Ç'ye göre) | 133 (+15 önceki Ç'ye göre) | 90 (+9 önceki Ç'ye göre) | +3.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| FMR LLC | $993.861.419 | 25.681.174 | 13,11% | Hisse senetleri |
| BlackRock, Inc. | $671.547.401 | 17.352.646 | 8,86% | Hisse senetleri |
| VANGUARD GROUP INC | $408.988.860 | 11.514.326 | 5,40% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $312.402.306 | 8.072.411 | 4,12% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $286.857.171 | 7.412.330 | 3,78% | Hisse senetleri |
| STATE STREET CORP | $269.542.365 | 6.964.919 | 3,56% | Hisse senetleri |
| JANUS HENDERSON GROUP PLC | $229.633.788 | 5.965.125 | 3,03% | Hisse senetleri |
| Fairmount Funds Management LLC | $212.982.277 | 5.503.418 | 2,81% | Hisse senetleri |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $193.736.225 | 5.006.104 | 2,56% | Hisse senetleri |
| TCG Crossover Management, LLC | $187.866.673 | 4.854.436 | 2,48% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $174.534.880 | 4.508.998 | 2,30% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $168.111.910 | 4.343.977 | 2,22% | Hisse senetleri |
| Kynam Capital Management, LP | $141.916.654 | 3.667.097 | 1,87% | Hisse senetleri |
| Polar Capital Holdings Plc | $125.113.424 | 3.232.905 | 1,65% | Hisse senetleri |
| Commodore Capital LP | $118.035.000 | 3.050.000 | 1,56% | Hisse senetleri |
| Invesco Ltd. | $100.973.759 | 2.609.141 | 1,33% | Hisse senetleri |
| Woodline Partners LP | $100.742.369 | 2.603.162 | 1,33% | Hisse senetleri |
| Pictet Asset Management Holding SA | $92.634.023 | 2.393.515 | 1,22% | Hisse senetleri |
| Octagon Capital Advisors LP | $90.945.000 | 2.350.000 | 1,20% | Hisse senetleri |
| RTW INVESTMENTS, LP | $89.359.113 | 2.309.021 | 1,18% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $88.570.098 | 2.288.633 | 1,17% | Hisse senetleri |
| Candriam S.C.A. | $80.742.121 | 2.088.369 | 1,07% | Hisse senetleri |
| Deep Track Capital, LP | $77.400.000 | 2.000.000 | 1,02% | Hisse senetleri |
| Siren, L.L.C. | $71.954.097 | 1.859.279 | 0,95% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $65.066.310 | 1.681.300 | 0,86% | Hisse senetleri |
| Venrock Adviser, LLC | $63.551.824 | 1.642.166 | 0,84% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $62.048.445 | 1.603.319 | 0,82% | Hisse senetleri |
| NORTHERN TRUST CORP | $60.288.021 | 1.557.830 | 0,80% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $56.087.910 | 1.449.300 | 0,74% | Hisse senetleri |
| Assenagon Asset Management S.A. | $55.795.957 | 1.441.756 | 0,74% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $55.713.759 | 1.439.632 | 0,74% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $55.455.537 | 1.432.957 | 0,73% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $49.563.361 | 1.280.707 | 0,65% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $46.962.837 | 1.213.510 | 0,62% | Hisse senetleri |
| Elmind Capital, LP | $45.307.638 | 1.170.740 | 0,60% | Hisse senetleri |
| UBS Group AG | $43.430.881 | 1.122.245 | 0,57% | Hisse senetleri |
| FRED ALGER MANAGEMENT, LLC | $41.518.521 | 1.072.830 | 0,55% | Hisse senetleri |
| Sofinnova Investments, Inc. | $40.060.228 | 1.035.148 | 0,53% | Hisse senetleri |
| EMERALD MUTUAL FUND ADVISERS TRUST | $39.914.329 | 1.031.378 | 0,53% | Hisse senetleri |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $39.558.482 | 1.022.183 | 0,52% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $38.551.702 | 996.168 | 0,51% | Hisse senetleri |
| Balyasny Asset Management L.P. | $36.952.424 | 954.843 | 0,49% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $36.871.696 | 952.757 | 0,49% | Hisse senetleri |
| MORGAN STANLEY | $36.444.817 | 941.725 | 0,48% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $35.699.937 | 922.479 | 0,47% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $35.128.454 | 907.712 | 0,46% | Hisse senetleri |
| Logos Global Management LP | $34.830.000 | 900.000 | 0,46% | Hisse senetleri |
| Squadron Capital Management LLC | $33.475.500 | 865.000 | 0,44% | Hisse senetleri |
| CITADEL ADVISORS LLC | $32.883.158 | 849.694 | 0,43% | Hisse senetleri |
| Point72 Asset Management, L.P. | $28.800.347 | 744.195 | 0,38% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×11 başvurular | 31 Mart 2026 | 8,60% | Değişiklik | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 25 içeriden öğrenenler · 11 yöneticiler · 13 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Andrew R Robbins | President and CEO | 19 Mayıs 2026 G | 160.000 | 0 | 0 | $0 |
| Charles Wilson | Chief Executive Officer | 01 Mart 2019 A | · | 0 | 0 | $0 |
| John L. Green | Chief Financial Officer | 26 Aralık 2025 S | 131.834 | 0 | 1 | $-2.978.360 |
| Matthew Scott Osborne | Chief Financial Officer | 11 Şubat 2020 A | · | 0 | 0 | $0 |
| John Edward Robinson | Chief Scientific Officer | 26 Aralık 2025 S | 140.002 | 0 | 1 | $-3.486.600 |
| Jessica Sachs | Chief Medical Officer | 26 Aralık 2025 S | 133.938 | 0 | 1 | $-3.198.245 |
| Evan Kearns | Chief Legal Officer | 26 Aralık 2025 S | 109.398 | 0 | 1 | $-2.515.500 |
| Cole Pinnow | Chief Commercial Officer | 17 Aralık 2025 A | 216.650 | 0 | 0 | $0 |
| Geoffrey Hodge | Chief Technical Officer | 11 Şubat 2020 A | · | 0 | 0 | $0 |
| Seth Ettenberg | Chief Scientific Officer | 11 Şubat 2020 A | 0 | 0 | 0 | $0 |
| Michael Vasconcelles | Chief Medical Officer | 01 Mart 2019 A | · | 0 | 0 | $0 |
| Arlene Morris | Yönetim kurulu üyesi | 27 Ağustos 2026 M | 0 | 0 | 2 | $-1.689.388 |
| Karen Jean Ferrante | Yönetim kurulu üyesi | 01 Temmuz 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Todd Shegog | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Matthew Ros | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Peter Harwin | Yönetim kurulu üyesi | 09 Haziran 2026 A | · | 0 | 0 | $0 |
| Fairmount Funds Management LLC | Yönetim kurulu üyesi | 31 Mart 2026 C | 5.503.418 | 0 | 2 | $-370.020.000 |
| Jorn Aldag | Yönetim kurulu üyesi | 01 Temmuz 2020 A | · | 0 | 0 | $0 |
| Bruce Booth | Yönetim kurulu üyesi | 01 Temmuz 2020 A | 3.361.535 | 0 | 0 | $0 |
| Liam Ratcliffe | Yönetim kurulu üyesi | 14 Haziran 2019 A | 897.773 | 0 | 0 | $0 |
| Robert J Perez | Yönetim kurulu üyesi | 14 Haziran 2019 A | · | 0 | 0 | $0 |
| Dario Campana | 10% sahip | 12 Mayıs 2020 S | 3.095.114 | 0 | 0 | $0 |
| FIL Ltd | · | 03 Nisan 2018 C | 1.138.274 | 0 | 0 | $0 |
| FMR LLC | · | 03 Nisan 2018 C | 23.240 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 35 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| LABU · Direxion Shares ETF Trust | 0,85% | 107.533 NS | 31 Temmuz 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,79% | 9.390 NS | 31 Temmuz 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,62% | 57.786 NS | 31 Temmuz 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 134.513 NS | 31 Temmuz 2026 | N-PORT |
| ESSC · Strategy Shares | 0,44% | 4.046 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,38% | 178.467 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,37% | 1.569.593 SH | 11 Eylül 2026 | Günlük |
| IBB · iShares Trust | 0,37% | 1.125.962 SH | 11 Eylül 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,37% | 12.272 SH | 02 Ekim 2026 | Günlük |
| FFSM · FIDELITY COVINGTON TRUST | 0,25% | 95.539 NS | 31 Temmuz 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,24% | 1.469 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 42.273 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,21% | 79.831 NS | 31 Temmuz 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,20% | 4.588 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,20% | 959.613 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,19% | 4.260.580 SH | 11 Eylül 2026 | Günlük |
| ISCG · iShares Trust | 0,17% | 49.190 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 85.339 SH | 19 Ağustos 2026 | Günlük |
| VBR · VANGUARD INDEX FUNDS | 0,13% | 2.363.019 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,08% | 3.722.357 SH | 19 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,07% | 59.663 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,07% | 1.958.933 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,07% | 368.585 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 58.328 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,04% | 8.633 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 31.254 SH | 02 Ekim 2026 | Günlük |
| TILT · FlexShares Trust | 0,01% | 7.426 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 5.158.077 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 133.924 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 13.697 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 36.815 SH | 19 Ağustos 2026 | Günlük |
| ITOT · iShares Trust | 0,01% | 228.048 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,01% | 44.772 SH | 10 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 6.956 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 19.041 SH | 11 Eylül 2026 | Günlük |
COGT Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 18 analist
AL
Medyan hedef
$55.00
+77,3%
8 44,4%
Güçlü Al
8 44,4%
Al
2 11,1%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
11 analist · 2026-10-04Ortalama hedef $55.82 +79,9%
← Tüm hedeflerin altında
Mevcut fiyat $31.02
Düşük$45.00
Ortalama$55.82
Yüksek$62.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 10, 2026